PCOS Is Now PMOS: What The Lancet's 2026 Name Change Means for Indian Women — and Why Ayurveda Saw It Coming

Published 13 May 2026 | Reviewed by Dr. Amruta Amrutkar, M.D. (Ayurveda), Women's Health Lead, AMRUT AYU CARE™

On 12 May 2026, The Lancet published a landmark Health Policy paper. The condition the world has called Polycystic Ovary Syndrome (PCOS) for decades has a new name. From now on, it is Polyendocrine Metabolic Ovarian Syndrome — PMOS.

This is not a rebrand. It is a correction. And for women in Pune who have struggled with irregular cycles, weight gain, acne, hair loss, infertility, and a label that never quite fit their experience, this change is overdue.

At AMRUT AYU CARE™, we welcome this shift. Ayurvedic Medicine has always understood this condition as a multi-system imbalance — not a problem confined to the ovaries. The new name finally reflects what classical Ayurveda described centuries ago.

What The Lancet Actually Said

The paper was led by Prof. Helena J. Teede and a consortium of 56 academic, clinical, and patient organisations worldwide. It is the result of a rigorous, multi-step global consensus process involving 14,360 survey responses from women living with the condition and from multidisciplinary health professionals across all regions of the world.[¹]

The conclusion was clear. The term "polycystic ovary" is inaccurate. Three reasons stood out:

1. The ovaries in this condition do not contain pathological cysts. The follicles seen on ultrasound are arrested in development. They are not true cysts.
2. The name reflects only one organ. The condition involves endocrine, metabolic, reproductive, psychological, and dermatological systems.
3. The misleading name has delayed diagnosis. Up to 70% of affected women remain undiagnosed.[¹]

The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS) captures three things the old name missed:

• Polyendocrine — multiple hormone systems are disturbed, including insulin, androgens, neuroendocrine signals, and ovarian hormones.
• Metabolic — insulin resistance is present in 85% of affected women, and in 75% of lean women with the condition. Obesity, type 2 diabetes, fatty liver, hypertension, and cardiovascular risk are all elevated.[¹]
• Ovarian — follicular and ovulatory disturbances remain a defining feature, without the misleading "cyst" reference.

Why This Matters for One in Eight Women

PMOS affects more than 170 million women worldwide during their reproductive years.[¹] In India, prevalence is estimated between 9% and 22% depending on region and diagnostic criteria. In Pune, our Women's Health OPD on Fridays sees this condition more than any other single complaint.

The features are familiar to anyone who has lived with it:

• Irregular or absent periods
• Acne, oily skin, and unwanted facial hair (hirsutism)
• Hair thinning on the scalp
• Weight gain around the abdomen
• Difficulty conceiving
• Mood changes, anxiety, low energy
• Insulin resistance and pre-diabetes
• Increased long-term risk of heart disease

The Lancet paper confirms what patients have always said. This is not "just an ovary problem." It is a whole-body condition.[¹]

The Ayurvedic Perspective: We Always Knew

Classical Ayurvedic texts do not use the words "polycystic" or "endocrine." But the description of Artava Kshaya (depletion or disturbance of menstrual tissue), combined with Medo Dhatu Dushti (disturbance of fat tissue) and Kapha-Vata Avarana (obstruction of Vata function by Kapha), maps almost exactly onto what modern medicine now calls PMOS.

In Ayurvedic understanding, this condition involves:

• Agni Mandya — weak digestive and metabolic fire, which corresponds to insulin resistance.
• Medo Dhatu Vriddhi — excess fat tissue, mirroring central adiposity and metabolic dysfunction.
• Artava Vaha Srotas Dushti — disturbance of the channels carrying reproductive hormones.
• Manovaha Srotas involvement — the mind-body axis, reflected today in the anxiety and depression seen in PMOS.

The new biomedical name validates a multi-system framework. Ayurvedic Medicine treats it as a multi-system condition. The two views finally align.

How AMRUT AYU CARE™ Approaches PMOS

Our Friday Women's Health OPD, led by Dr. Amruta Amrutkar (M.D. Ayurveda, 12+ years), addresses the root causes rather than only the symptoms. Treatment supports the body in restoring hormonal balance, metabolic function, and ovulatory rhythm.

A typical PMOS protocol at our Ghorpadi and Hadapsar Panchakarma centres includes:

1. Detailed dosha and prakruti assessment — every woman's PMOS pattern is different. Kapha-dominant, Vata-dominant, and Pitta-aggravated presentations need different protocols.
2. Panchakarma therapies — specifically Virechana (medicated purgation) to clear excess Pitta and Kapha, Basti (medicated enema) to regulate Vata and support reproductive function, and Udvartana (herbal powder massage) to address metabolic stagnation.
3. Ayurvedic Medicine formulations — classical preparations like Shatavari, Ashoka, Lodhra, Guduchi, and Triphala, individualised by the consulting physician.
4. Ahara and Vihara guidance — dietary and lifestyle protocols that address insulin resistance and metabolic dysfunction at the source.
5. Stress and sleep management — addressing the neuroendocrine axis through Yoga, Pranayama, and structured daily rhythm (Dinacharya).

This approach supports the body in addressing the polyendocrine, metabolic, and ovarian features together. It does not promise quick fixes. It works with the body's own intelligence over a structured 3 to 6 month cycle.

What the Name Change Means for You

If you have been diagnosed with PCOS, your diagnosis is still valid. The condition has not changed. The name has.

Over the next three years, The Lancet paper notes a managed global transition.[¹] The World Health Organization, ICD coding systems, electronic health records, medical textbooks, and the International PCOS Guideline (used in 195 countries and next updated in 2028) will gradually adopt PMOS.

Practically, this means:

• Your reports, prescriptions, and insurance documents may continue to say "PCOS" for some time.
• New patient education materials will use "PMOS" or both names together.
• The diagnostic criteria remain the same: oligo-anovulation, clinical or biochemical hyperandrogenism, and polycystic ovaries on ultrasound or elevated AMH. Two out of three are required for adults.[¹]

Why a Name Matters

Words shape understanding. The old name made millions of women believe their problem was "cysts on the ovaries." Many were told to live with it. Many were never screened for the metabolic risks that come with it — heart disease, type 2 diabetes, and fatty liver.

The new name puts those risks where they belong: at the centre of the conversation.

It also reduces stigma. The reproductive framing of "PCOS" carried distress in cultures where fertility is heavily valued. PMOS reframes the condition as endocrine and metabolic first, ovarian second.[¹]

Book Your Friday Women's Health Consultation

If you suspect PMOS, or if you have been managing PCOS for years without lasting relief, our Friday Women's Health OPD is the right starting point. We see patients across all five branches:

• Ghorpadi (Main, Full Panchakarma)
• Hadapsar (Full Panchakarma)
• Wagholi (Consultation)
• Kharadi (Online)
• Viman Nagar (Online)

📞 8698282507 | 🌐 amrutayucare.in

Reference

1. Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. Published online May 12, 2026. doi: 10.1016/S0140-6736(26)00717-8. Open Access under CC BY 4.0.

Medical disclaimer: This article is for educational purposes. It does not replace individual medical advice. Ayurvedic Medicine supports and manages PMOS as a multi-system condition. It is not a substitute for emergency or specialist medical care. Please consult a qualified Ayurvedic physician for a personalised treatment plan.

AMRUT AYU CARE™ — Authentic Ayurvedic Medicine, Five Branches Across Pune.